HuGE Literature Finder
Records 1-3
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
PloS one 2017 12 (5): e0175674. Caspell-Garcia Chelsea, Simuni Tanya, Tosun-Turgut Duygu, Wu I-Wei, Zhang Yu, Nalls Mike, Singleton Andrew, Shaw Leslie A, Kang Ju-Hee, Trojanowski John Q, Siderowf Andrew, Coffey Christopher, Lasch Shirley, Aarsland Dag, Burn David, Chahine Lana M, Espay Alberto J, Foster Eric D, Hawkins Keith A, Litvan Irene, Richard Irene, Weintraub Daniel, |
The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease.
Neurobiology of aging 2010 Jun 31 (6): 1064-8. Rowe J B, Hughes L, Williams-Gray C H, Bishop S, Fallon S, Barker R A, Owen A |
Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease.
Neuroscience letters 2001 Feb 298 (2): 131-4. Lee M S, Lyoo C H, Ulmanen I, Syvänen A C, Rinne J |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 05, 2021
- Content source: